Squamous Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Squamous Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed [Phase 3]
A Phase 3 trial comparing IBI363 to docetaxel in advanced squamous non-small cell lung cancer after standard treatments have failed is curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013) [Phase 2]
Phase 2 study evaluating Intismeran Autogene (V940) or placebo with pembrolizumab and chemotherapy in metastatic squamous non-small cell lun…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed [Phase 3]
A Phase 3 trial comparing IBI363 with docetaxel in patients with advanced squamous non-small cell lung cancer resistant to prior treatments;…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer [Phase 3]
A Phase III trial is comparing HB0025 plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment of advanced squamous…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Describe a Phase II/III trial evaluating HLX07 plus serplulimab and chemotherapy versus a control combination of serplulimab or pembrolizuma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) [Phase 1]
A Phase 1 trial evaluating CVHNLC in combination with pembrolizumab for squamous non-small cell lung cancer, with the study currently not ye…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update on AK112 in combination with chemotherapy for advanced squamous non-small cell lung cancer; the study is cur…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating platinum-based chemotherapy with or without INCMGA00012 (retifanlimab) in metastatic non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial updating results for platinum-based chemotherapy with or without INCMGA00012 (an anti-PD-1 antibody) in metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1b/2 trial of AMG 479 with paclitaxel and carboplatin as first-line therapy for advanced squamous non-small cell lung cancer. The stud…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy [Phase 2]
Phase 2 trial updating the combination of recombinant human endostatin with Envafolimab and Synchronal radiochemotherapy in locally advanced…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC [Phase 3]
Phase 3 randomized trial evaluating HLX10 plus carboplatin-nab-paclitaxel vs placebo for first-line treatment inStage IIIB/IIIC or IV non-sm…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating trilaciclib given before chemotherapy plus tislelizumab as a first-line treatment for advanced sq…
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: A Study to Assess the Efficacy and Safety of ABTL0812 [Phase 1, Phase 2]
Phase 1/2 trial evaluating ABTL0812 for endometrial cancer and squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial) [Phase 3]
Phase 3 trial comparing early switch maintenance with delayed second-line nivolumab in advanced squamous non-small cell lung cancer; results…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: A Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC [Phase 2]
Phase 2 trial update evaluating HLX07 + HLX10 with or without chemotherapy versus HLX10 with chemotherapy in first-line squamous non-small-c…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC [Phase 2]
A Phase 2 trial exploring Envafolimab with chemotherapy and recombinant human endostatin as first-line treatment for squamous non-small cell…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC [Phase 2]
Phase 2 trial investigating avelumab and cetuximab with gemcitabine and cisplatin in squamous non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
A completed clinical trial evaluating afatinib following pembrolizumab and chemotherapy in metastatic squamous cell carcinoma of the lung; r…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC [Phase 3]
A Phase 3 trial evaluating sintilimab in combination with gemcitabine and platinum chemotherapy as first-line therapy for advanced or metast…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing veliparib with carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in untreated advanced or metastatic…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU) [Phase 4]
Phase 4 trial update for paclitaxel liposome in squamous non-small-cell lung cancer is reported as ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] [Phase 3]
Phase 3 trial comparing atezolizumab combined with carboplatin + paclitaxel or carboplatin + nab-paclitaxel versus carboplatin + nab-paclita…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial investigating anlotinib hydrochloride capsules combined with chemotherapy for squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407) [Phase 3]
Phase 3 trial MK-3475-407/KEYNOTE-407 evaluated pembrolizumab plus chemotherapy versus chemotherapy alone as first-line treatment for metast…